Concepedia
Statistics
Publications
4
Citations
245
H-Index
Active since
2016
Affiliations
GlaxoSmithKline (United States)(Current)
GlaxoSmithKline (United Kingdom)
The University of Texas MD Anderson Cancer Center
Heather L. Jackson is an author at GlaxoSmithKline (United States) specializing in oncology, cancer immunotherapy, and tumor immunology.
Publications per year
2016–2021
Belantamab Mafodotin (GSK2857916) Drives Immunogenic Cell Death and Immune-mediated Antitumor Responses<i>In Vivo</i>
Rocío Montes de, Alireza Alavi, Nick Vitali et al. · Molecular Cancer Therapeutics · 2021 · 111 citations · Full text
Life Sciences, Immunology, Oncology +17
Radiation Followed by OX40 Stimulation Drives Local and Abscopal Antitumor Effects in an Anti–PD1-Resistant Lung Tumor Model
Sharareh Niknam, Hampartsoum B. Barsoumian, Jonathan E. Schoenhals et al. · Clinical Cancer Research · 2018 · 60 citations
Medicine, Oncology, Radiation Oncology +16
Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8+ T Cells and Synergizes with PI3Kβ Inhibition in PTEN Loss Melanoma
Weiyi Peng, Leila J. Williams, Chunyu Xu et al. · Clinical Cancer Research · 2019 · 46 citations · Full text
Novel Bispecific Domain Antibody to LRP6 Inhibits Wnt and R-spondin Ligand-Induced Wnt Signaling and Tumor Growth
Heather L. Jackson, David Granger, Gavin C. Jones et al. · Molecular Cancer Research · 2016 · 28 citations · Full text
Medicine, Cancer Biology, Oncology +16
1–4 of 4